OTA report assails profits on new drugs.
L
L
Wagner
E
E
Weissenstein
D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D005069:Evaluation Studies as Topic; D007449:Investments / Q000191:economics; D012109:Research Support as Topic / Q000191:economics; D014481:United States; D014491:United States Office of Technology Assessment